Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bone.2020.115354 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.
Mol Neurodegener
December 2024
Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
Correction: CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma.
J Exp Clin Cancer Res
December 2024
National Translational Science Center for Molecular Medicine, Department of Cell Biology, Fourth Military Medical University, Xi'an, 710032, P. R. China.
Corrigendum to "Cathepsin B-responsive multifunctional peptide conjugated gold nanorods for mitochondrial targeting and precise photothermal cancer therapy" [J. Colloid Interface Sci. 601 (2021) 714-726].
J Colloid Interface Sci
January 2025
Department of Polymer Materials, Zhejiang Sci-Tech University, Hangzhou 310018, China. Electronic address:
Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity".
ACS Pharmacol Transl Sci
April 2024
Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tübingen Center for Academic Drug Discovery, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, Tübingen 72076, Germany.
[This corrects the article DOI: 10.1021/acsptsci.3c00313.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!